Litigation
Moderna Therapeutics, Inc. v. Arbutus Biopharma Corporation
Final Written DecisionIPR2018-00739
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2018-03-05
- Terminated
- 2019-09-11
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Inter partes review of US 9,364,435. The PTAB confirmed claims 7-8, 10-11, 13 and 16-20, but held claims 1-6, 9, 12 and 14-15 unpatentable as anticipated, leaving the '435 patent with a subset of claims.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).